No, Anixa Biosciences (ANIX) does not pay a dividend to its shareholders. As a clinical-stage biotechnology enterprise operating without commercial product revenue while funding intensive research, laboratory trials, and immunotherapy developments, the company retains all available capital to support ongoing clinical pipeline advancement rather than issuing cash distributions.